9MW1411

N/A

Report date: 2026/03/27 20:01:50

Base Information

Drug Name9MW1411
Drug Alias Name9MW14119-MW14119-MW-1411
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionToxin A inhibitors
TargetsToxin A
Therapy Area/IndicationsSkin Diseases, InfectiousStaphylococcal Skin InfectionsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesMabwell (Shanghai) Bioscience Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesMabwell (Shanghai) Bioscience Co Ltd
Active IndicationsN/A
Inactive IndicationsSkin Diseases, InfectiousStaphylococcal Skin InfectionsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A